Sterner Stuff | GenomeWeb

Sterner Stuff

A new bill introduced by US Congressman Edward Markey (D-Mass.) to the House of Representatives calls for tougher reporting requirements to ClinicalTrials.gov, says Peter Mansell at PharmaTimes. The proposed legislation, called the Trial and Experimental Studies Transparency, or TEST, Act of 2012, would require that results from all clinical trials be posted to the database within a year of the trial's end.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.